SCOPUS 정보 검색 플랫폼

Seminars in Hematology

Volumn 38, Issue 1 SUPPL. 1, 2001, Pages 73-76

Iron chelation: New therapies

(1) Galanello, Renzo a

a Osp Regionale per le Microcitemie (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DEFERASIROX; DEFERIPRONE; DEFEROXAMINE MESYLATE; ION; IRON CHELATING AGENT;

CLINICAL PRACTICE; CLINICAL TRIAL; COMPUTER MODEL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DESIGN; DRUG EFFICACY; DRUG RELEASE; DRUG SAFETY; DRUG STRUCTURE; DRUG TOLERANCE; HUMAN; IRON CHELATION; IRON OVERLOAD; PRIORITY JOURNAL;

EID: 0035136103 PISSN: 00371963 EISSN: None Source Type: Journal
DOI: 10.1016/s0037-1963(01)90063-0 Document Type: Conference Paper

Times cited : (24)

References (8)

1
- 0032887235
- Deferiprone: A review of its clinical potential in iron overload in beta-thalassaemia major and other transfusion-dependent diseases
- (1999) Drugs , vol.58 , pp. 553-578
- Barman Balfour, J.A.¹ Foster, R.H.²

2
- 0006224757
- Presented at the World Congress on Iron Metabolism, Bioiron, Sorrento, Italy, May 23-28, (abstr)
- (1999) A new depot formulation of desferrioxamine (ICL749B) given as subcutaneous bolus injection in transfusion dependent β-thalassemic patients: Update on the dose-finding program
- Cappellini, M.D.¹ Alberti, D.² Dimitrijevic, S.³

3
- 0006212975
- Presented at the 7th International Conference on Thalassemia and the Haemoglobinopathies, Bangkok, Thailand, May 31-June 4, (abstr)
- (1999) A novel oral iron chelator (ICL670A): Update on a phase I single-dose safety study
- Galanello, R.¹ Loehrer, F.² Alberti, D.³

4
- 0024802647
- Modulation of deferoxamine toxicity and clearance by covalent attachment to biocompatible polymers
- (1989) Proc Natl Acad Sci USA , vol.86 , pp. 10108-10112
- Hallaway, P.E.¹ Eaton, J.W.² Panter, S.³

5
- 0006163280
- Presented at the World Congress on Iron Metabolism, Bioiron, Sorrento, Italy, May 23-28, (abstr)
- (1999) ICL670A: A new, potent, orally active chelator
- Nick, H.P.¹ Acklin, P.² Faller, B.³

6
- 0031001278
- Iron-chelating therapy and the treatment of thalassemia
- (1997) Blood , vol.89 , pp. 739-761
- Olivieri, N.F.¹ Brittenham, G.²

7
- 0010983188
- Studies of iron excretion and non-transferrin-bound plasma iron (NTBPI) following a single infusion of hydroxyethyl starch-deferoxamine (HESDFO): A new approach to iron chelation therapy
- suppl 1, abstr
- (1996) Blood , vol.88
- Olivieri, N.F.¹ Nisbet-Brown, E.² Srichairatanakool, S.³

8
- 0000644975
- Subcutaneous depot desferrioxamine (CGH 749B); relationship of pharmacokinetics to efficacy and drug metabolism
- suppl 1, abstr
- (1997) Blood , vol.90 , pp. 265
- Porter, J.B.¹ Alberti, D.² Hassan, I.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.